Skip to main content
. 2017 Jun 10;174(22):3898–3913. doi: 10.1111/bph.13818

Figure 1.

Figure 1

Pro‐atherogenic and inflammatory pathways targeted by prospective anti‐atherosclerotic antibodies and inhibitors.